Back

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Atrial fibrillation - Stroke prevention Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Xiaoyan Li

Princeton (United States of America)

10 More presentations in this session

Presentation thumbnail
Associate Professor H. Yu (Seoul, KR)
Abstract
Presentation thumbnail
Doctor M. Esteve Pastor (Murcia, ES)
Abstract
Presentation thumbnail
Mr S. van der Wall (Haarlem, NL)
Abstract Slides
Presentation thumbnail
Doctor Z. Salpagarova (Moscow, RU)
Abstract
Presentation thumbnail
Doctor S. Aeschbacher (Basel, CH)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Atrial fibrillation - Stroke prevention

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis
2 September 2019
thumbnail
Congress Presentation
Plasma levels of direct oral anticoagulants in non-valvular atrial fibrillation patients at the time of acute cardioembolic or bleeding events
28 August 2023
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry- is dosing according to renal function appropriate?
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources